Total Funding
54
52
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
48311
Cerecin is a healthcare company that develops a novel evidence-based therapeutics and products that aim to help people.
- Bruce Morimoto: Vice PresidentPast Role: Celerion, Vice President, Scientific Affairs
Judith Walker: Chief Medical Officer
About the Company
Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people.
Cerecin develops novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating
neurological diseases.
The company was founded in 2001 and is based in Denver, Colorado.
